Literature DB >> 6206002

Occult melanoma in lymph nodes detected by antiserum to S-100 protein.

A J Cochran, D R Wen, H R Herschman.   

Abstract

Sections of 1,273 nodes from 58 patients with melanoma were stained in an immunoperoxidase assay using an antiserum to S-100 protein and aminoethyl carbazole as indicator. By the hematoxylin and eosin (H. and E.) technique, 128 nodes were seen to contain melanoma (10%); by the anti-S-100 protein technique, 363 (29%) were found to be tumor-positive. The additional tumor-positive nodes contained single tumor cells or small groups of tumor cells and were adjacent to nodes that were partly or wholly replaced by melanoma. Penetration of nodes by single tumor cells was seldom seen in node groups containing no tumor that was visible on H. and E. staining. The anti-S-100 protein approach more accurately identified those patients who would die of their recurrent disease less than 5 years after lymphadectomy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206002     DOI: 10.1002/ijc.2910340204

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Diagnostic immunopathology.

Authors:  P A Cancilla; A J Cochran; F Naeim; J W Said
Journal:  West J Med       Date:  1986-07

2.  Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

Authors:  Donald L Morton; Alistair J Cochran; John F Thompson; Robert Elashoff; Richard Essner; Edwin C Glass; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; He-jing Wang
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

Review 3.  Management of the regional lymph nodes in patients with cutaneous malignant melanoma.

Authors:  A J Cochran; D R Wen; D L Morton
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

4.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

Authors:  D L Morton; J F Thompson; R Essner; R Elashoff; S L Stern; O E Nieweg; D F Roses; C P Karakousis; N Mozzillo; D Reintgen; H J Wang; E C Glass; A J Cochran
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

5.  Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.

Authors:  Hiroya Takeuchi; Donald L Morton; Christine Kuo; Roderick R Turner; David Elashoff; Robert Elashoff; Bret Taback; Akihide Fujimoto; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544

6.  The use of polytetrafluoroethylene to facilitate the vascular access in recurrent melanoma to limbs.

Authors:  Roberta Ruggeri; Tiziana Camerini; Roberto Patuzzo; Andrea Maurichi; Riccardo Pirovano; Ilaria Mattavelli; Federica Crippa; Elena Tolomio; Daniele Moglia; Annabella Di Florio; Mario Santinami
Journal:  Int J Surg Case Rep       Date:  2012-09-27

Review 7.  The role of sentinel lymph node biopsy in the management of melanoma.

Authors:  Farin Amersi; Donald L Morton
Journal:  Adv Surg       Date:  2007

8.  Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.

Authors:  Yasufumi Goto; Soldano Ferrone; Takaaki Arigami; Minoru Kitago; Atsushi Tanemura; Eiji Sunami; Sandy L Nguyen; Roderick R Turner; Donald L Morton; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

9.  Malignant melanoma. Practical considerations concerning prophylactic regional lymph node dissection.

Authors:  A W Silberman
Journal:  Ann Surg       Date:  1987-08       Impact factor: 12.969

10.  Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma.

Authors:  X Wang; R Heller; N VanVoorhis; C W Cruse; F Glass; N Fenske; C Berman; J Leo-Messina; D Rappaport; K Wells
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.